4. Waselenko JK, MacVittie TJ, Blakely WF, et al. Strategic National Stockpile Radiation Working Group. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med. 2004;140(12):1037–1051. [PubMed] 5. Gorin NC, Fliedner TM, Gourmelon P, et al. Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol. 2006;85(10):671–679. [PubMed] 7. Schünemann HJ, Oxman AD, Brozek J, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336(7653):1106–1110. [PMC free article] [PubMed] 9. Maurer DC. Nuclear detection: preliminary observations on the Domestic Nuclear Detection Office’s efforts to develop a global nuclear detection architecture. Testimony before the Committee on Homeland Security and Governmental Affairs; US Senate: [Accessed June 10, 2011]. http://www.gao.gov/products/GAO-08-999T Published July 16, 2008. 11. Mettler FA, Jr., Voelz GL. Major radiation exposure—what to expect and how to respond. N Engl J Med. 2002;346(20):1554–1561. [PubMed]
12. Mettler FA, Upton AC. Deterministic effects of ionizing radiation. In: Mettler FA, Upton AC, editors. Medical Effects of Radiation. 3rd ed. Philadelphia: Saunders Elsevier; 2008.
14. Meineke V, Fliedner TM. Radiation-induced multi-organ involvement and failure: challenges for radiation accident medical management and future research. BJR Suppl. 2005;27:196–200. [PubMed] 15. Gourmelon P, Marquette C, Agay D, Mathieu J, Clarenc¸on D. Involvement of the central nervous system in radiation-induced multi-organ dysfunction and/or failure. BJR Suppl. 2005;27:62–68. [PubMed] 16. Jackson WL, Jr., Gallagher C, Myhand RC, Waselenko JK. Medical management of patients with multiple organ dysfunction arising from acute radiation syndrome. BJR Suppl. 2005;27:161–168. [PubMed] 17. Warren S, Bowers JZ. The acute radiation syndrome in man. Ann Intern Med. 1950;32(2):207–216. [PubMed] 18. Brooks JW, Evans EI, Ham WT, Jr., Reid JD. The influence of external body radiation on mortality from thermal burns. Ann Surg. 1952;136(3):533–545. [PubMed]
19. Ledney GD, Elliot TB, Moore MM. Modulations of mortality by tissue trauma and sepsis in mice after radiation injury. In: Mossman KL, Mills WA, editors. The Biological Basis of Radiation Protection Practices. Baltimore, MD: Williams & Wilkins; 1992. pp. 202–217.
20. Alexander GA, Swartz HM, Amundson SA, et al. BiodosEPR-2006 Meeting: acute dosimetry consensus committee recommendations on biodosimetry applications in events involving uses of radiation by terrorists and accidents. Radiat Meas. 2007;42(Suppl):972–996.
22. Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation. Health Risks From Exposure to Low Levels of Ionizing Radiation, BEIR VII Phase 2. Washington, DC: National Academies Press; 2006. pp. 267–312.
23. Anno GH, Young RW, Bloom RM, Mercier JR. Dose response relationships for acute ionizing-radiation lethality. Health Phys. 2003;84(5):565–575. [PubMed] 24. Bender MA, Gooch PC. Somatic chromosome aberrations induced by human whole-body irradiation: the “Recuplex” criticality accident. Radiat Res. 1966;29(4):568–582. [PubMed] 25. Goans RE, Holloway EC, Berger ME, Ricks RC. Early dose assessment in criticality accidents. Health Phys. 2001;81(4):446–449. [PubMed] 26. Demidenko E, Williams BB, Swartz HM. Radiation dose prediction using data on time to emesis in the case of nuclear terrorism. Radiat Res. 2009;171(3):310–319. [PMC free article] [PubMed]
27. Fliedner TM, Friesecke I, Beyrer K. Medical Management of Radiation Accidents: Manual on Acute Radiation Syndrome. Oxford, UK: British Institute of Radiobiology; 2001.
28. Wilkins RC, Romm H, Kao TC, et al. Interlaboratory comparison of the dicentric chromosome assay for radiation biodosimetry in mass casualty events. Radiat Res. 2008;169(5):551–560. [PubMed] 29. Lloyd DC, Edwards AA, Moquet JE, Guerrero-Carbajal YC. The role of cytogenetics in early triage of radiation casualties. Appl Radiat Isot. 2000;52(5):1107–1112. [PubMed] 30. Wojcik A, Lloyd D, Romm H, Roy L. Biological dosimetry for triage of casualties in a large-scale radiological emergency:capacity of the EU member states. Radiat Prot Dosimetry. 2010;138(4):397–401. [PubMed] 31. Parker DD, Parker JC. Estimating radiation dose from time to emesis and lymphocyte depletion. Health Phys. 2007;93(6):701–704. [PubMed] 32. Flynn DF, Goans RE. Nuclear terrorism: triage and medical management of radiation and combined-injury casualties. Surg Clin North Am. 2006;86(3):601–636. [PubMed]
33. Andrews GA. Medical management of accidental total-body irradiation. In: Hubner K, Fry S, editors. Medical Basis for Radiation Accident Preparedness. New York: Elsevier Press; 1980.
34. Blakely WF, Ossetrova NI, Manglapus GL, et al. Amylase and blood cell-count hematological radiation-injury biomarkers in a rhesus monkey radiation model-use of multiparameter and integrated biological dosimetry. Radiat Meas. 2007;42(Suppl):1164–1170.
35. Dainiak N, Berger P, Albanese J. Relevance and feasibility of multiparameter assessment for management of mass casualties from a radiological event. Exp Hematol. 2007;35(4) Suppl 1:17–23. [PubMed] 36. Monti P, Wysocki J, van der Meeren A, Griffiths NM. The contribution of radiation-induced injury to the gastrointestinal tract in the development of multi-organ dysfunction syndrome or failure. BJR Suppl. 2005;27(Suppl):89–94. [PubMed]
37. Hauer-Jensen M, Kumar KS, Wang J, et al. Intestinal toxicity in radiation-and combined injury: significance, mechanisms, and countermeasures. In: Larche RA, editor. Global Terrorism Issues and Developments. Hauppauge, NY: Nova Science Publishers; 2008.
38. Pizzarello DJ, Witcofski TL. Medical Radiation Biology. Philadelphia: Lea & Febiger; 1982.
39. Lushbaugh CC. Proceedings of a Symposium on the Control of Exposure of Public to Ionizing Radiation in the Event of Accident or Attack. Bethesda, Md: National Council on Radiation Protection and Measurement, held on April 27–28, 1981; 1982. The impact of estimates on radiation emergency management; pp. 46–47.
40. Dainiak N, Waselenko JK, Armitage JO, et al. The hematologist and radiation casualties. Hematology Am Soc Hematol Educ Progr; 2003. pp. 473–496. [PubMed] 41. Sigsgaard T, Herrstedt J, Handberg J, Kjaer M, Dombernowsky P. Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy. J Clin Oncol. 2001;19(7):2091–2097. [PubMed] 42. Schmoll HJ, Aapro MS, Poli-Bigelli S, et al. Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone for antiemetic efficacy in high-dose cisplatin treatment. Ann Oncol. 2006;17(6):1000–1006. [PubMed] 43. Walsh T, Morris AK, Holle LM, et al. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial. Bone Marrow Transplant. 2004;34(11):963–968. [PubMed] 44. Abdelsayed GG. Management of radiation-induced nausea and vomiting. Exp Hematol. 2007;35(4) Suppl 1:34–36. [PubMed] 45. Roila F, Hesketh PJ, Herrstedt J. Antiemetic Subcommitte of the Multinational Association of Supportive Care in Cancer. Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol. 2006;17(1):20–28. [PubMed] 46. Kris MG, Hesketh PJ, Somerfield MR, et al. American Society of Clinical Oncology. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol. 2006;24(18):2932–2947. [PubMed] 47. Harris AG, O’Dorisio TM, Woltering EA, et al. Diarrhea Management Consensus Development Panel. Consensus statement: octreotide dose titration in secretory diarrhea. Dig Dis Sci. 1995;40(7):1464–1473. [PubMed] 48. Wadler S, Benson AB, III, Engelking C, et al. Recommended guidelines for the treatment of chemotherapy-induced diarrhea. J Clin Oncol. 1998;16(9):3169–3178. [PubMed] 49. Ippoliti C. Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients. Am J Health Syst Pharm. 1998;55(15):1573–1580. [PubMed] 50. Szilagyi A, Shrier I. Systematic review: the use of somatostatin or octreotide in refractory diarrhoea. Aliment Pharmacol Ther. 2001;15(12):1889–1897. [PubMed] 51. Yavuz MN, Yavuz AA, Aydin F, Can G, Kavgaci H. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study. Int J Radiat Oncol Biol Phys. 2002;54(1):195–202. [PubMed] 52. Hermsen JL, Sano Y, Kudsk KA. Food fight! Parenteral nutrition, enteral stimulation and gut-derived mucosal immunity. Langenbecks Arch Surg. 2009;394(1):17–30. [PMC free article] [PubMed] 53. McClave SA, Martindale RG, Vanek VW, et al. A.S.P.E.N. Board of Directors; American College of Critical Care Medicine; Society of Critical Care Medicine. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) JPEN J Parenter Enteral Nutr. 2009;33(3):277–316. [PubMed] 54. Worthington P, Gilbert KA, Wagner BA. Parenteral nutrition for the acutely ill. AACN Clin Issues. 2000;11(4):559–579. quiz 634–636. [PubMed] 55. International Atomic Energy Agency. IAEA reports on Tokaimura accident. Health Phys. 2000;78(2):231. [PubMed]
56. Meineke V. Medical and Organization Challenges Resulting From a Radiological Nuclear Emergency. Acute Radiation Syndrome of the Skin: New Aspects in Pathophysiology and Treatments Following Radiation Exposure. Washington, DC: Radiation Injury Treatment Network; 2007.
57. Hoashi T, Okochi H, Kadono T, et al. A case of acute radiation syndrome from the dermatological aspect. Br J Dermatol. 2008;158(3):597–602. [PubMed]
58. Peter RU. Klinische Aspekte des kutanen Strahlensyndroms nach Strahle-nunfallen—Erfahrungen von Goiania und Tschernobyl. Akuel Dermatol. 1993;19:364–367.
59. Peter RU. The cutaneous radiation syndrome. In: MacVittie TJ, Weiss JF, Browne D, editors. Advances in the Treatment of Radiation Injuries. Oxford, UK: Elsevier; 1999.
60. Goldschmidt H. Hautarzt. 4. Vol. 33. Dermatologic roentgen therapy and radio-carcinogenesis; 1982. pp. 183–190. [PubMed] 61. Mu¨ller K, Meineke V. Radiation-induced alterations in cytokine production by skin cells. Exp Hematol. 2007;35(4) Suppl 1:96–104. [PubMed] 62. Meineke V, van Beuningen D, Sohns T, Fliedner TM. Medical management principles for radiation accidents. Mil Med. 2003;168(3):219–222. [PubMed] 63. Meineke V. The role of damage to the cutaneous system in radiation-induced multi-organ failure. BJR Suppl. 2005;27:85–99. [PubMed] 64. Roy L, Bertho JM, Souidi M, Vozenin MC, Voisin P, Benderitter M. Biochemical approach to prediction of multiple organ dysfunction syndrome. BJR Suppl. 2005;27:146–151. [PubMed] 65. Bertho JM, Roy L, Souidi M, et al. New biological indicators to evaluate and monitor radiation-induced damage: an accident case report. Radiat Res. 2008;169(5):543–550. [PubMed] 66. Berger ME, Christensen DM, Lowry PC, Jones OW, Wiley AL. Medical management of radiation injuries: current approaches. Occup Med (Lond) 2006;56(3):162–172. [PubMed] 67. Chambers JA, Purdue GF. Radiation injury and the surgeon. J Am Coll Surg. 2007;204(1):128–139. [PubMed] 68. Orgill DP. Excision and skin grafting of thermal burns. N Engl J Med. 2009;360(9):893–901. [PubMed] 69. Foster K, Greenhalgh D, Gamelli RL, et al. FS 4IU VH S/D Clinical Study Group. Efficacy and safety of a fibrin sealant for adherence of autologous skin grafts to burn wounds: results of a phase 3 clinical study. J Burn Care Res. 2008;29(2):293–303. [PubMed] 70. Brown JB, Mcdowell F, Fryer MP. Surgical treatment of radiation burns. Surg Gynecol Obstet. 1949;88(5):609–622. [PubMed] 71. Berger ME, Hurtado R, Dunlap J, et al. Accidental radiation injury to the hand: anatomical and physiological considerations. Health Phys. 1997;72(3):343–348. [PubMed] 72. Geraci JP, Mariano MS, Jackson KL, Taylor DA, Still ER. Effects of dexamethasone on late radiation injury following partial-body and local organ exposures. Radiat Res. 1992;129(1):61–70. [PubMed] 73. DiCarlo AL, Hatchett RJ, Kaminski JM, et al. Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. report of an NIAID Workshop, March 26–27 2007. Radiat Res. 2008;169(6):712–721. [PubMed] 74. Peter RU, Gottlo¨ber P. Management of cutaneous radiation injuries: diagnostic and therapeutic principles of the cutaneous radiation syndrome. Mil Med. 2002;167(2) Suppl:110–112. [PubMed] 75. Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MW. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol. 1999;155(4):1137–1146. [PubMed] 76. Tattini C, Manchio J, Zaporojan V, et al. Role of TGF-beta and FGF in the treatment of radiation-impaired wounds using a novel drug delivery system. Plast Reconstr Surg. 2008;122(4):1036–1045. [PubMed] 77. Franc¸ois S, Bensidhoum M, Mouiseddine M, et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells. 2006;24(4):1020–1029. [PubMed] 78. Lataillade JJ, Doucet C, Bey E, et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med. 2007;2(5):785–794. [PubMed] 79. Chapel A, Bertho JM, Bensidhoum M, et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med. 2003;5(12):1028–1038. [PubMed] 80. Miuram M, Miura Y, Padilla-Nash HM, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells. 2006;24(4):1095–1103. [PubMed] 81. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147. [PubMed] 82. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726–736. [PubMed] 83. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110(10):3499–3506. [PubMed] 84. Le Blanc K, Samuelsson H, Gustafsson B, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia. 2007;21(8):1733–1738. [PubMed] 85. Le Blanc K, Frassoni F, Ball L, et al. Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371(9624):1579–1586. [PubMed] 86. Ball LM, Bernardo ME, Roelofs H, et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stemcell transplantation. Blood. 2007;110(7):2764–2767. [PubMed] 87. Doucet C, Ernou I, Zhang Y, et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005;205(2):228–236. [PubMed] 88. Anno GH, Baum SJ, Withers HR, Young RW. Symptomatology of acute radiation effects in humans after exposure to doses of 0.5–30 Gy. Health Phys. 1989;56(6):821–838. [PubMed]
89. Prasad KN. Radiation damage to the nervous system. In: Prasad KN, editor. Handbook of Radiobiology. 2nd ed. Boca Raton, FL: CRC Press; 1995. pp. 161–170.
90. Walker RI, Cerveny RJ. Medical Consequences of Nuclear Warfare. Falls Church, VA: Office of the Surgeon General; 1989.
91. Cancer Pain Relief. 2nd ed. Geneva: World Health Organization; 1996.
92. TMT Handbook Consortium. [Accessed July 2, 2009];Triage, monitoring and treatment of people exposed to ionizing radiation after a malevolent act. http://www.tmthandbook.org. 93. Collins DL. Behavioral differences of irradiated persons associated with the Kyshtym, Chelyabinsk and Chernobyl nuclear accidents. Mil Med. 1992;157(10):548–552. [PubMed] 94. Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356(4):348–359. [PubMed]
95. Maekawa K. Overview of medical care for highly exposed victims in Tokaimura accident. In: Ricks RC, Berger ME, O’Hara FM, editors. The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims. Boca Raton, FL: Partheon Publishing Group; 2002. pp. 313–318.
96. Asano S. Multi-organ involvement: lessons from the experience of one victim of the Tokai-mura criticality accident. BJR Suppl. 2005;27:9–12. [PubMed] 97. Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol. 2002;30(6):513–528. [PubMed] 98. Dellinger RP, Levy MM, Carlet JM, et al. International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296–327. [PubMed] 99. Akashi M. Role of infection and bleeding in multiple organ involvement and failure. BJR Suppl. 2005;27:69–74. [PubMed] 100. Hirama T, Tanosaki S, Kandatsu S, et al. Initial medical management of patients severely irradiated in the Tokai-mura criticality accident. Br J Radiol. 2003;76(904):246–253. [PubMed]
101. Crawford SW. Diagnosis and management of pulmonary problems associated with radiation injury. In: RC Ricks, Berger ME, O’Hara FM., editors. The Medical Basis for Radiation Accident Preparedeness: The Clinical Care of Victims. Boca Raton, FL: Parthenon Publishing Group; 2002. pp. 131–138.
102. Ghafoori P, Marks LB, Vujaskovic Z, Kelsey CR. Radiation-induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 2008;22(1):37–47. discussion 52–53. [PubMed] 103. Johnston AM. Pulmonary effects of combined blast injury and radiation poisoning. J R Army Med Corps. 2004;150(3) Suppl 1:22–26. [PubMed] 104. Mefferd JM, Donaldson SS, Link MP. Pediatric Hodgkin’s disease: pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys. 1989;16(3):679–685. [PubMed] 105. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301–1308. [PubMed] 106. Manthous CA, Jackson WL., Jr. The 9–11 Commission’s invitation to imagine: a pathophysiology-based approach to critical care of nuclear explosion victims. Crit Care Med. 2007;35(3):716–723. [PubMed] 107. Barrett A, Depledge MH, Powles RL. Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation. Int J Radiat Oncol Biol Phys. 1983;9(7):1029–1033. [PubMed] 108. Depledge MH, Barrett A. Powles RL. Lung function after bone marrow grafting. Int J Radiat Oncol Biol Phys. 1983;9(2):145–151. [PubMed] 109. Mancebo J, Fernández R, Blanch L, et al. A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006;173(11):1233–1239. [PubMed] 110. Villar J, Pérez-Méndez L, Lo´pez J, et al. HELP Network. An early PEEP/ FIO2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2007;176(8):795–804. [PubMed] 111. Annane D, Sébille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862–871. [PubMed] 112. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 1999;27(4):723–732. [PubMed] 113. Ishii T, Futami S, Nishida M, et al. Brief note and evaluation of acuteradiation syndrome and treatment of a Tokai-mura criticality accident patient. J Radiat Res (Tokyo) 2001;42(Suppl):S167–S182. [PubMed] 114. Akashi M, Hirama T, Tanosaki S, et al. Initial symptoms of acute radiation syndrome in the JCO criticality accident in Tokai-mura. J Radiat Res (Tokyo) 2001;42(Suppl):S157–S166. [PubMed] 115. Brook AD, Ahrens TS, Schaiff R, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999;27(12):2609–2615. [PubMed] 116. D’Amico R, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ. 1998;316(7140):1275–1285. [PMC free article] [PubMed] 117. Bergmans DC, Bonten MJ, Gaillard CA, et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med. 2001;164(3):382–388. [PubMed] 118. de Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet. 2003;362(9389):1011–1016. [PubMed] 119. de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360(1):20–31. [PubMed] 120. Karas JS, Stanbury JB. Fatal radiation syndrome from an accidental nuclear excursion. N Engl J Med. 1965;272:755–761. [PubMed] 121. Gale RP. Immediate medical consequences of nuclear accidents. Lessons from Chernobyl. JAMA. 1987;258(5):625–628. [PubMed]
122. International Atomic Energy Agency. The Radiation Accident at the Irradiation Facility in Nesvizh. IAEA STI/PUB/1010. Vienna: International Atomic Energy Agency; 1996.
123. Coleman CN, Blakely WF, Fike JR, et al. Molecular and cellular biology of moderate-dose (1–10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17–18, 2001. Radiat Res. 2003;159(6):812–834. [PubMed] 124. Moulder JE, Cohen EP. Radiation-induced multi-organ involvement and failure: the contribution of radiation effects on the renal system. BJR Suppl. 2005;27:82–88. [PubMed] 125. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–1131. [PMC free article] [PubMed] 126. Bernard GR, Vincent JL, Laterre PF, et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699–709. [PubMed] 127. Vinsonneau C, Camus C, Combes A, et al. Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemo-dialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006;368(9533):379–385. [PubMed] 128. Clement S, Braithwaite SS, Magee MF, et al. American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553–591. [PubMed] 129. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933–944. [PubMed] 130. Comi RJ. Glucose control in the intensive care unit: a roller coaster ride or a swinging pendulum? Ann Intern Med. 2009;150(11):809–811. [PubMed] 131. Finfer S, Chittock DR, Su SY, et al. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–1297. [PubMed] 132. Inzucchi SE. Siegel MD Glucose control in the ICU—how tight is too tight? N Engl J Med. 2009;360(13):1346–1349. [PubMed]
133. Berger ME, Sadoff RL. Psychological support of radiation-accident patients, families, and staff. In: Ricks RC, erger MEB, O’Hara FM, editors. The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims. Boca Raton, FL: Pantheon Press; 2002. pp. 191–200.
134. Devereaux AV, Dichter JR, Christian MD, et al. Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: a framework for allocation of scarce resources in mass critical care: from a Task Force for Mass Critical Care summit meeting, January 26–27, 2007, Chicago, IL. Chest. 2008;133(5) Suppl:51S–66S. [PubMed] 135. Gostin L. Public health strategies for pandemic influenza: ethics and the law. JAMA. 2006;295(14):1700–1704. [PubMed] 136. Persad G, Wertheimer A, Emanuel EJ. Principles for allocation of scarce medical interventions. Lancet. 2009;373(9661):423–431. [PubMed] 137. Emanuel EJ. Wertheimer A. Public health Who should get influenza vaccine when not all can? Science. 2006;312(5775):854–855. [PubMed] 138. White DB, Katz MH, Luce JM, Lo B. Who should receive life support during a public health emergency? Using ethical principles to improve allocation decisions. Ann Intern Med. 2009;150(2):132–138. [PMC free article] [PubMed] 139. Tabery J, Mackett CW., III University of Pittsburgh Medical Center Pandemic Influenza Task Force’s Triage Review Board. Ethics of triage in the event of an influenza pandemic. Disaster Med Public Health Prep. 2008;2(2):114–118. [PubMed]
140. Sandel M. Justice: What’s the Right Thing to Do? New York: Farrar, Straus & Giroux; 2009.
141. Fink SL. Worst case: rethinking tertiary triage protocols in pandemics and other health emergencies. Crit Care. 2010;14(1):103. [PMC free article] [PubMed] 142. Coleman CN, Knebel AR, Hick JL, et al. Scarce resources for nuclear detonation: project overview and challenges. Disaster Med Public Health Prep. 2011;5(Suppl 1):S13–S19. [PubMed] 143. Qaseem A, Snow V, Shekelle P, et al. Clinical Efficacy Assessment Sub-committee of the American College of Physicians. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;148(2):141–146. [PubMed]
144. Curado MPSB, Neto C, Helou S. Psychological aspects of the radiation-accident in Goiania: a general overview on victims and population. In: Ricks RC, Berger ME, O’Hara M, editors. The Medical Basis for Radiation Accident Preparedness III: The Psychological Perspective. New York: Elsevier; 1991. pp. 143–154.
145. Havenaar J, Rumyantzeva G, Kasyanenko A, et al. Health effects of the Chernobyl disaster: illness or illness behavior? A comparative general health survey in two former Soviet regions. Environ Health Perspect. 1997;105(Suppl 6):1533–1537. [PMC free article] [PubMed] 146. Pastel RH. Radiophobia: long-term psychological consequences of Chernobyl. Mil Med. 2002;167(2) Suppl:134–136. [PubMed] 148. DiGiovanni C., Jr. Domestic terrorism with chemical or biological agents: psychiatric aspects. Am J Psychiatry. 1999;156(10):1500–1505. [PubMed] 149. Pynoos RS, Goenjian AK, Steinberg AM. A public mental health approach to the postdisaster treatment of children and adolescents. Child Adolesc Psychiatr Clin N Am. 1998;7(1):195–210. x. [PubMed]
150. Upton AC. Radiation injury. In: Goldman L, Ausiello D, editors. Goldman’s Cecil Medicine. 23rd ed. Philadelphia: Saunders Elsevier; 2008. pp. 90–96.
151. Tochner ZA, Lehavi O, Glatstein E. Radiation bioterrorism. In: Kasper DL, Fauci AS, Longo D, et al., editors. Harrison’s Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005. pp. 1294–1300.
155. Planning guidance for protection and recovery following radiological dispersal device (RDD) and improvised nuclear device (IND) incidents, DHS/ FEMA, Z-RIN 1660-za02. [Accessed June 16, 2011]; http://ogcms.energy.gov/73fr45029.pdf. Published August 1, 2008. 163. Waeckerle JF, Seamans S, Whiteside M, et al. Task Force of Health Care and Emergency Services Professionals on Preparedness for Nuclear, Biologiccal, and Chemical Incidents. Executive summary: developing objectives, content, and competencies for the training of emergency medical technicians, emergency physicians, emergency nurses to care for casualties resulting from nuclear, biological, or chemical incidents. Ann Emerg Med. 2001;37(6):587–601. [PubMed] 164. Homeland Security Council Interagency Policy Coordination Subcommittee for Preparedness & Response to Radiological and Nuclear Threats. [Accessed June 16, 2011];Planning guidance for response to a nuclear detonation. http://remm.nlm.gov/planning-guidance.pdf. Published January 16, 2009. 165. Becker SM, Middleton SA. Improving hospital preparedness for radiological terrorism: perspectives from emergency department physicians and nurses. Disaster Med Public Health Prep. 2008;2(3):174–184. [PubMed] 166. Veenema TG, Walden B, Feinstein N, Williams JP. Factors affecting hospital-based nurses’ willingness to respond to a radiation emergency. Disaster Med Public Health Prep. 2008;2(4):224–229. [PubMed]
167. Clark RC, Mayer RE. e-Learning and the Science of Instruction: Proven Guidelines for Consumers and Designers of Multimedia Learning. San Francisco: Pfeiffer/John Wiley & Sons; 2008.
168. Oak Ridge Institute for Science and Education (ORISE)/Radiation Emergency Assistance Center/Training Site. (REACT/TS) [Accessed August 19, 2009]; http://orise.orau.gov/reacts.
171. Mettler FA, Guskova AK, Gusev IA. Medical Management of Radiation Accidents. 2nd ed. Albuquerque: University of New Mexico; 2001.
172. Waller E, Millage K, Blakely WF, et al. Overview of hazard assessment and emergency planning software of use to RN first responders. Health Phys. 2009;97(2):145–156. [PubMed] 173. Radiation Event Medical Management (REMM) [Accessed June 16, 2011];Guidance for health care providers. http://remm.nlm.gov. 174. Centers for Disease Control and Prevention. [Accessed June 16, 2011];Radiation emergencies. www.bt.cdc.gov/radiation. 178. Fliedner TM, Chao NJ, Bader JL, et al. Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop. Stem Cells. 2009;27(5):1205–1211. [PMC free article] [PubMed] 181. Coleman CN, Hrdina C, Bader JL, et al. Medical response to a radiologic/nuclear event: integrated plan from the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services. Ann Emerg Med. 2009;53(2):213–222. [PubMed]